Recce Pharmaceuticals Ltd. (AU:RCE)
ASX:RCE
Holding AU:RCE?
Track your performance easily

Recce Pharmaceuticals Ltd. (RCE) Financial Statements

8 Followers

Recce Pharmaceuticals Ltd. Financial Overview

Recce Pharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.091; its P/E ratio is -5.51; Recce Pharmaceuticals Ltd. is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 11.58MAU$ 20.87MAU$ 2.68MAU$ 403.38KAU$ 679.72K
Total AssetsAU$ 12.62MAU$ 21.68MAU$ 3.24MAU$ 922.18KAU$ 1.14M
Total DebtAU$ 74.76KAU$ 126.95KAU$ 83.23KAU$ 0.00AU$ 0.00
Net DebtAU$ -11.51MAU$ -20.75MAU$ -2.60MAU$ -403.38KAU$ -679.72K
Total LiabilitiesAU$ 2.56MAU$ 1.18MAU$ 931.53KAU$ 1.33MAU$ 448.82K
Stockholders EquityAU$ 10.06MAU$ 20.50MAU$ 2.31MAU$ -405.60KAU$ 694.91K
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Recce Pharmaceuticals Ltd. Earnings and Revenue History

Recce Pharmaceuticals Ltd. Debt to Assets

Recce Pharmaceuticals Ltd. Cash Flow

Recce Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis